AB928 is an Orally Active, Selective Dual A2aR and A2bR Antagonist
Adenosine is generated through the hydrolysis of extracellular adenosine mono phosphate (AMP) by the ectonucleotidase CD73. It is an important mechanism for immunosuppression in cancer development. A2aR and A2bR drive…